Chris Trethewey

Clinical researcher.

About

Chris Trethewey is a clinical researcher working in haematology and cancer research in the UK. His work focuses on liquid biopsy approaches for monitoring blood cancers.

GitHub

ProbeScope example output

ProbeScope

A command-line tool for generating per-gene coverage track plots from BAM files, overlaid on panel target BED annotations with MANE-Select exon models.

ONCOSIEVE logo

ONCOSIEVE

Pan-cancer somatic variant curation pipeline that aggregates COSMIC, GENIE, ClinVar, OncoKB, and other curated sources to build a tiered whitelist for rescuing clinically relevant low-VAF variants.

DELVE banner

DELVE

Deep-sequencing and Evaluation of Lymphoid Variant Effects.

Publications

Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study

2026 Journal of Clinical Oncology

The DIRECT study: A roadmap for ctDNA-based risk prediction, molecular profiling and MRD detection in Diffuse Large B Cell Lymphoma

2025 medRxiv (preprint)

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma

2024 eJHaem

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

2023 Blood Advances

Molecular Profiling of Circulating Tumour DNA in Aggressive Lymphoid Malignancies

2023 Thesis

Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type

2022 HemaSphere

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma

2020 Blood Advances

Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent Venetoclax

2019 JCO Precision Oncology

Full list available on ORCID.